We are now enrolling qualified sites across the U.S. and in Europe for the CorEvitas Adolescent Alopecia Areata Registry. If you are interested in becoming a participating site, please get in touch using the link below.
Alopecia areata (AA) is an autoimmune disease characterized by transient non-scarring hair loss on the scalp and other hair-bearing parts of the body. It is a heterogeneous disease, can have an unpredictable clinical course with variable time between episodes of relapse and remission, and is more common among adolescents than adults. The impact of AA extends beyond hair loss, as patients have higher risks of developing other autoimmune diseases and comorbidities. The psychosocial implications for adolescents living with alopecia areata can include embarrassment, self-consciousness, and subsequent reduced participation in school or extracurricular activities.
This registry prospectively collects detailed patient-level data on a cohort of adolescent subjects, to evaluate the long-term safety and effectiveness of routine treatments in real-world clinical care. The collected data will support research on the natural history of the disease, treatment effectiveness and safety, adolescent growth and development, drug risk-benefit evaluation, and unmet need. Additionally, it will provide real-world evidence to inform clinical decision-making for patients and providers.
Granular, longitudinal outcome measures are collected during regular visits, including clinician-reported AA outcomes, lab measures and treatment history, as well as patient-reported outcomes (PROs) assessing symptom impact and quality of life. Drug safety data are also collected, including serious adverse events and other adverse events of special interest.
Read the press release, here.
Assistant Professor of Dermatology, Harvard Medical School
Director, Lahey Hair Loss Center of Excellence & Hair Academic Innovative Research Unit
Associate Professor Adjunct--Dermatology, Yale School of Medicine
Associate Professor of Dermatology, Yale School of Medicine
